Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

10.36
+0.03000.29%
Post-market: 10.360.00000.00%19:30 EDT
Volume:2.83M
Turnover:29.25M
Market Cap:2.32B
PE:14.79
High:10.51
Open:10.32
Low:10.25
Close:10.33
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:0.92
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.68
PE(LYR):17.27

Loading ...

ADMA Biologics Faces Federal Securities Lawsuit Over Alleged Channel Stuffing Scheme and Undisclosed Related Party Transactions

TIPRANKS
·
Jun 16

Nutrien, CAVA, Cracker Barrel, ADMA, CRISPR Trending With Analysts

TIPRANKS
·
Jun 13

ADMA Biologics Faces Securities Fraud Class Action, Investors Sustain Heavy Losses

Deep News
·
Jun 12

Why ADMA Biologics (ADMA) Is Up 9.3% After Securities Fraud Class Actions Over ASCENIV Sales Practices

Simply Wall St.
·
Jun 11

ADMA Biologics Shareholders Back Board, Auditor and Pay

TIPRANKS
·
Jun 03

ADMA Biologics holds annual shareholder meeting

Reuters
·
Jun 03

Insider Makes Bold Move With Fresh ADMA Biologics Buy

TIPRANKS
·
May 29

ADMA Biologics director Jerrold B. Grossman acquires 6,400 common shares worth $50,624

Reuters
·
May 29

ADMA Biologics director Jerrold B. Grossman acquires USD 100,125 common shares

Reuters
·
May 14

A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations

Simply Wall St.
·
May 13

ADMA Biologics director Jerrold B Grossman acquires $100,125 in common shares

Reuters
·
May 13

Stock Track | ADMA Biologics Soars 5.31% Intraday on Strong Q1 Earnings Fueled by ASCENIV

Stock Track
·
May 08

ADMA Biologics Earnings Call: ASCENIV Fuels Profits

TIPRANKS
·
May 08

ADMA Biologics Is Maintained at Outperform by Mizuho

Dow Jones
·
May 07

ADMA Biologics Inc : Mizuho Cuts Target Price to $20 From $24

THOMSON REUTERS
·
May 07

Stock Track | ADMA Biologics Plunges 21.63% in Pre-market on Earnings Miss and Withdrawn Long-Term Guidance

Stock Track
·
May 07

Stock Track | ADMA Biologics Plunges 24% Post-Market on Earnings Miss and Withdrawn Long-Term Guidance

Stock Track
·
May 07

Stock Track | ADMA Biologics Plunges 26.88% After-Hours on Earnings Miss and Withdrawn Long-Term Guidance

Stock Track
·
May 07

ADMA Biologics withdraws long-term outlook on competitive dynamics in PDT & IG market

Reuters
·
May 07

ADMA Biologics 1Q26 adjusted net income rises 22% to $40.7 million; revenue flat at $114.5 million

Reuters
·
May 07